Literature DB >> 7240750

The presence of platelet-activating factor (PAF) in normal human mixed saliva.

C P Cox, M L Wardlow, R Jorgensen, R S Farr.   

Abstract

This report describes PAF activity in normal human mixed saliva from each of 24 randomly selected donors. The human salivary PAF (HS-PAF) was similar to rabbit basophil PAF (acetyl glyceryl ether phosphorylcholine or AGEPC) with respect to the following characteristics: 1. HS-PAF co-chromatographed with the standard rabbit basophil AGEPC and with synthetic AGEPC. 2. HS-PAF and AGEPC were unaffected by hirudin, indomethacin, and creatine phosphate/creatine phosphokinase, the respective inhibitors of platelet activation induced by thrombin, arachidonic acid, and ADP. 3. HS-PAF and AGEPC were inactivated by a 5-min incubation with ALF, the acid-labile factor in normal human serum that rapidly destroys AGEPC. 4. HS-PAF was demonstrated to be functionally similar to AGEPC by cross-desensitization experiments. In the absence of Ca++, HS-PAF and AGEPC cross-desensitized washed rabbit platelets to subsequent stimulation by either HS-PAF or AGEPC after recalcification. 5. HS-PAF was demonstrated to be structurally similar to AGEPC by several simple chemical tests for functional groups.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240750

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Calcium-dependent biosynthesis of platelet-activating factor by submandibular gland cells.

Authors:  T Dohi; K Morita; S Kitayama; A Tsujimoto
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Quantitation by radioimmunoassay of PAF in human saliva.

Authors:  S J Cooney; M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor.

Authors:  R J Raggers; I Vogels; G van Meer
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

4.  Modulation of bacterial aggregation by PMN and platelet extracts.

Authors:  D Malamud; R Goldman; N S Taichman
Journal:  Inflammation       Date:  1983-06       Impact factor: 4.092

5.  Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms.

Authors:  E Kloprogge; J W Akkerman
Journal:  Biochem J       Date:  1986-12-01       Impact factor: 3.857

6.  A specific, sensitive and high-capacity immunoassay for PAF.

Authors:  B A Baldo; M A Smal; A C McCaskill
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

7.  Inhibitor(s) of platelet-activating factor (PAF) in human saliva.

Authors:  M A Smal; B A Baldo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

8.  Platelet-activating factor levels of serum and gingival crevicular fluid in nonsmoking patients with periodontitis and/or coronary heart disease.

Authors:  Hui Chen; Pei Zheng; Haihua Zhu; Jianhua Zhu; Lili Zhao; Nour Eddine El Mokhtari; Jörg Eberhard; Markus Lins; Søren Jepsen
Journal:  Clin Oral Investig       Date:  2009-10-14       Impact factor: 3.573

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.